EMA recommends extended indications for Glaxo's Cervarix The Committee for Medicinal Products for Human Use adopted a positive opinion recommending a variation to the terms of the marketing authorization for the medicinal product Cervarix from GlaxoSmithKline Biologicals. The CHMP adopted an extension to the therapeutic indication for the prevention of premalignant genital, cervical, vulvar and vaginal, lesions causally related to certain oncogenic Human Papillomavirus types.
News For GSK From The Last 14 Days
Check below for free stories on GSK the last two weeks.
Ligand says partner GSK submits application for Promacta Ligand Pharmaceuticals (LGND) said its partner GlaxoSmithKline (GSK) announced today the submission of a supplemental New Drug Application to the FDA for Promacta for the treatment of cytopenias in patients with severe aplastic anaemia who have had an insufficient response to immunosuppressive therapy.